Can Thrombolysis Prevent Ischemic Heart Failure?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In the present era of thrombolysis, congestive heart failure secondary to (sub)acute coronary artery obstruction can be reduced to a considerable extent or even avoided altogether. Evidence from several recent trials in humans, aimed at restoring perfusion of the jeopardized myocardium - and thus preserving normal ventricular function - is presented. It is clear that thrombolysis, provided it is instituted within 4 h of onset of symptoms in patients with a large area of the myocardium at risk, can prevent ischemic heart failure.

Related collections

Author and article information

Journal

Journal ID (publisher-id): CRD

Journal ID (nlm-ta): Cardiology

Journal ID (doi): 10.1159/issn.0008-6312

Title: Cardiology

Publisher: S. Karger AG

ISBN: 978-3-8055-4929-5

ISBN: 978-3-318-01863-9

ISSN (Print): 0008-6312

ISSN (Electronic): 1421-9751

Publication date Subscription-year: 1988

Publication date (Print): 1988

Publication date (Electronic): 11 November 2008

Volume: 75

Issue: Suppl 1

Pages: 90-102

Affiliations

Thorax Center, University Hospital, Erasmus University, Rotterdam, and the Netherlands Interuniversity Institute, Utrecht, The Netherlands

Article

Publisher ID: 174448 Other ID: Cardiology 1988;75:90–102

DOI: 10.1159/000174448

PubMed ID: 3069220

SO-VID: ea05cae1-af19-4707-8033-529f4d389e4d

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Call for Papers: Novel Methods in Vascular and Lymphatic Physiology

Submit here before June 30, 2025

Can Thrombolysis Prevent Ischemic Heart Failure?

Read this article at

Abstract

Related collections

Karger: Cardiovascular System

Author and article information

Journal

Affiliations

Article

History

Page count

Categories

Comments

Comment on this article

Similar content 492